🇺🇸 FDA
Patent

US 11166990

Methods and compositions for treating ulcerative colitis

granted A61KA61K35/741A61K35/742

Quick answer

US patent 11166990 (Methods and compositions for treating ulcerative colitis) held by Finch Therapeutics Holdings LLC expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Finch Therapeutics Holdings LLC
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/741, A61K35/742, A61K9/08, A61K9/16